HomeCompareCABJF vs JNJ

CABJF vs JNJ: Dividend Comparison 2026

CABJF yields 2.78% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CABJF wins by $23.0K in total portfolio value
10 years
CABJF
CABJF
● Live price
2.78%
Share price
$117.23
Annual div
$3.26
5Y div CAGR
27.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$43.0K
Annual income
$5,907.13
Full CABJF calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — CABJF vs JNJ

📍 CABJF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCABJFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CABJF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CABJF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CABJF
Annual income on $10K today (after 15% tax)
$236.39/yr
After 10yr DRIP, annual income (after tax)
$5,021.06/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, CABJF beats the other by $4,317.45/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CABJF + JNJ for your $10,000?

CABJF: 50%JNJ: 50%
100% JNJ50/50100% CABJF
Portfolio after 10yr
$31.5K
Annual income
$3,367.45/yr
Blended yield
10.69%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

CABJF
No analyst data
Altman Z
2.2
Piotroski
5/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CABJF buys
0
JNJ buys
0
No recent congressional trades found for CABJF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCABJFJNJ
Forward yield2.78%3.36%
Annual dividend / share$3.26$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR27.4%5.8%
Portfolio after 10y$43.0K$20.0K
Annual income after 10y$5,907.13$827.78
Total dividends collected$19.8K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: CABJF vs JNJ ($10,000, DRIP)

YearCABJF PortfolioCABJF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,054$354.30$10,676$355.77+$378.00CABJF
2$12,294$466.33$11,407$389.39+$887.00CABJF
3$13,773$617.52$12,198$426.53+$1.6KCABJF
4$15,560$823.65$13,056$467.62+$2.5KCABJF
5$17,757$1,107.98$13,987$513.12+$3.8KCABJF
6$20,506$1,505.50$14,998$563.56+$5.5KCABJF
7$24,011$2,069.99$16,098$619.52+$7.9KCABJF
8$28,578$2,885.96$17,295$681.69+$11.3KCABJF
9$34,668$4,089.71$18,599$750.82+$16.1KCABJF
10$43,002$5,907.13$20,022$827.78+$23.0KCABJF

CABJF vs JNJ: Complete Analysis 2026

CABJFStock

Carlsberg A/S produces and sells beer and other beverage products in Denmark. It offers core, and craft and specialty beers; and alcohol-free brews. The company provides its products primarily under the Carlsberg, Tuborg, Feldschlösschen, Baltika, Chongqing, 1664 Blanc, Grimbergen, Ringnes, and Somersby brand names. Carlsberg A/S also exports its products to approximately 100 countries worldwide. The company was founded in 1847 and is headquartered in Copenhagen, Denmark.

Full CABJF Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this CABJF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CABJF vs SCHDCABJF vs JEPICABJF vs OCABJF vs KOCABJF vs MAINCABJF vs ABBVCABJF vs MRKCABJF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.